Drug Injury Watch: European Medicines Agency (EMA) Committee Recommends Further Restrictions On Use
Drug Injury Watch: European Medicines Agency (EMA) Committee Recommends Further Restrictions On Use Of Depakote / Depakene / Depacon By Women Of Childbearing Age Cites Higher Risks Of Neural Tube Defects Like Spina Bifida, Hypospadias, And Other Birth Defects As Well As Increased Risk Of Autism Spectrum Disorder http://www.drug-injury.com/druginjurycom/2014/10/european-medicine-valproate-restrictions-pregancy-depakote-birth-defects-depacon-autism-depakene-side-effects.html
Contributor
About
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
Related Documents in Personal Injury
- Drug Injury Watch: Mirapex / Requip / Neupro: Significant Increased Risk Of Compulsive Behaviors --
- Drug Injury Watch: Some Patients Who Stopped Taking Cymbalta Have Suffered From Extended And Severe
- Drug Injury Watch: The Link Between Popular Erectile Dysfunction (ED) Drug Viagra And Melanoma Has A
Categories
- Articles 313
- Bankruptcy 44
- Business 135
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4